Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-17-021588
Filing Date
2017-03-20
Accepted
2017-03-20 08:41:37
Documents
1
Period of Report
2016-12-23

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1526
  Complete submission text file 0001209191-17-021588.txt   2876
Mailing Address 25134 RYE CANYON LOOP SUITE 300 VALENCIA CA 91355
Business Address 25134 RYE CANYON LOOP SUITE 300 VALENCIA CA 91355 6617755300
MANNKIND CORP (Issuer) CIK: 0000899460 (see all company filings)

EIN.: 133607736 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799
Business Address
Tross Stuart A (Reporting) CIK: 0001589641 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-50865 | Film No.: 17700138